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Background: Polychlorinated biphenyls (PCBs) are persistent organic pollutants (POPs) with harmful effects in
animals and humans. Although PCB 153 is one of the most abundant among PCBs detected in animal tissues,
its mechanism of toxicity is not well understood. Only few studies have been conducted to explore genes and
pathways affected by PCB 153 by using high throughput transcriptomics approaches. To obtain better insights into
toxicity mechanisms, we treated juvenile Atlantic cod (Gadus morhua) with PCB 153 (0.5, 2 and 8 mg/kg body weight)
for 2 weeks and performed gene expression analysis in the liver using oligonucleotide arrays.
Results: Whole-genome gene expression analysis detected about 160 differentially regulated genes. Functional
enrichment, interactome, network and gene set enrichment analysis of the differentially regulated genes suggested
that pathways associated with cell cycle, lipid metabolism, immune response, apoptosis and stress response were
among the top significantly enriched. Particularly, genes coding for proteins in DNA replication/cell cycle pathways and
enzymes of lipid biosynthesis were up-regulated suggesting increased cell proliferation and lipogenesis, respectively.
Conclusions: PCB 153 appears to activate cell proliferation and lipogenic genes in cod liver. Transcriptional up-regulation
of marker genes for lipid biosynthesis resembles lipogenic effects previously reported for persistent organic pollutants
(POPs) and other environmental chemicals. Our results provide new insights into mechanisms of PCB 153 induced
toxicity.Background
Polychlorinated biphenyls (PCBs) are a class of com-
pounds composed of 209 congeners previously used as
industrial chemicals, for example in electrical equipment
as flame retardants, in paints, pesticides, lubricants and
sealants [1]. Although PCBs were banned in the late
1970s in the Western world, they are still one of the
most problematic environmental contaminants due to
their extreme persistence in the environment [2]. Be-
cause of their lipophilic nature and resistance to meta-
bolic degradation, PCBs bioaccumulate in animals and
biomagnify in the food chain [1]. Consumption of fish
from contaminated areas is one of the main sources of* Correspondence: Fekadu.Yadetie@mbi.uib.no
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unless otherwise stated.exposure to humans [3]. Based on chemical structure,
PCBs are classified into two major groups with different
modes of toxicity, i.e. the dioxin-like co-planar PCBs
that bind the aryl hydrocarbon receptor (AhR) (e.g. PCB
126) and the non-coplanar PCBs such as PCB 153 [1,4].
The co-planar PCBs have toxicity mechanisms mainly
mediated by AhR, with a range of toxic effects including
carcinogenicity, developmental toxicity, neurotoxicity,
immune suppression and endocrine disruption [1]. The
non-coplanar PCBs such as PCB 153 do not bind to and
activate AhR, and their mechanisms of toxicity are at
present less well understood. The non-coplanar PCBs such
as PCB 153 may act via the steroid and xenobiotic receptor
(SXR), also known as pregnane X receptor (PXR), and the
constitutive androstane receptor (CAR) [5,6].
PCB 153 is one of the PCB congeners often detectable
in biological samples [1,4], and it is commonly used as aLtd. This is an Open Access article distributed under the terms of the Creative
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coplanar) PCB congeners in toxicological investigations.
It is among the most persistent congeners, with resi-
dence time in the environment exceeding 100 years [2].
Toxic effects of PCB 153 include possible endocrine dis-
ruption [7,8], neurotoxicity [9], and liver tumor promo-
tion [10]. Accumulating evidences suggest that PCBs
and other persistent organic pollutants (POPs) may also
act as metabolic disruptors contributing to growing inci-
dence of metabolic diseases [11-17]. A recent study
showed that PCB 153 exacerbated obesity in mice when
administered in combination with a high-fat-diet result-
ing in increased visceral adiposity, hepatic steatosis,
plasma adipokines, as well as up-regulation and down-
regulation of genes for hepatic lipid biosynthesis and
degradation, respectively [18]. In mouse fibroblast 3T3-
L1 cells, PCB 153 and other environmental chemicals
have been shown to promote adipogenesis [16,19,20].
Studies using zebrafish (Danio rerio) suggest that fish
can be useful models in exploring effects of environmen-
tal chemicals that may act as metabolic disruptors
[21-23]. To date, no studies have explored effects PCB
153 toxicity in fish liver using high throughput ap-
proaches, perhaps partly due to lack of sequenced and
annotated genomes for many fish species. The Atlantic
cod is a commercially important species that is also
commonly used in monitoring environmental pollution
and laboratory toxicological investigations [9,24-26]. The
sequencing of its genome [27] has recently enabled us to
apply genomic approaches to study toxicant effects in
this organism [25,28]. Exposure to individual PCB conge-
ners, such as PCB 153, and subsequent analysis using global
approaches like transcriptome assays should enable a
better understanding of the toxic effects and the mecha-
nisms involved. Such mechanistic toxicogenomics studies
are increasingly recognized as important components in
developing models that can help in risk assessment of
environmental contaminants [29-31]. Furthermore, high
throughput transcriptomics approaches may facilitate iden-
tification of new biomarkers that can be applied in im-
proved monitoring of pollution in the aquatic environment.
The aim of this study was to map the range of molecular
targets of PCB 153 and gain better insights into its toxicity
mechanisms in the liver of Atlantic cod, using recently deve-
loped oligonucleotide arrays [28]. A genome-wide trans-
criptome analysis of Atlantic cod liver was performed after
exposure to PCB 153, and various bioinformatics approaches
were applied to explore the major genes and pathways
affected, and the possible toxicity mechanisms involved.
Results and discussion
Differentially regulated genes
Analysis of the microarray data resulted in 160 candidate
genes differentially regulated in the highest dose (8 mg/kgBW PCB 153) group, using SAM (Significance Analysis
of Microarrays) at FDR (False Discovery Rate) ≤ 10%
(Additional file 1:Table S1). Five genes found to be
differentially regulated by qPCR (Quantitative real-time
polymerase chain reaction) assay (see below) were also in-
cluded in Additional file 1: Table S1. This list of 165 diffe-
rentially regulated genes was used for pathway enrichment
analysis in DAVID (Database for Annotation, Visualization
and Integrated Discovery) and MetaCore (see below).
Although no differentially regulated genes were detected
for the lower 0.5 and 2 mg/kg BW PCB 153 doses (at the
10% FDR cut-off), a dose–response trend is apparent in
the expression of the differentially regulated genes as indi-
cated by hierarchical clustering analysis (Figure 1). In the
hierarchical clustering, the PCB 153 treated samples are
well separated from the control samples, and the dose
groups are co- clustered except one (2 mg/kg BW) sample
that was grouped with the lowest dose group. In general
high individual variability was observed in the microarray
data, which combined with a limited number of samples
(n = 3-4), appear to have contributed to moderate levels of
statistical significance for differential regulation. Thus,
Gene Set Enrichment Analysis (GSEA), which is an inde-
pendent approach for pathway enrichment analysis that
uses the whole set of genes without pre-selection [32], was
also performed in addition to pathway analysis using
DAVID and MetaCore performed with the differentially
regulated genes. In addition, selected genes in the affected
pathways were assayed by qPCR on a larger sample size to
confirm the microarray data (see below).
qPCR assay
To confirm the microarray results in a larger number of
samples (n = 8–10 per group), the mRNA levels of 10
up-regulated genes selected based on their relevance in
the most enriched lipid metabolism and cell cycle related
pathways were analyzed by qPCR (Figure 2). Half of
these genes were selected from the differentially regu-
lated list (Additional file 1: Table S1). Another five genes
(FABP7, TMM97, PPARG, SREBP1 and PCNA) that were
up-regulated by microarray but not at significant levels
(FDR >10) were also included in the PCR assay. A dose–
response trend was observed for all the genes and statis-
tical analysis using one-way ANOVA showed 6 of the 10
genes were significantly up-regulated in at least one dose
group of PCB 153 treated fish as determined by qPCR
assays (Figures 2A-J), thus confirming and strengthening
the microarray results.
Validation of the microarray method by qPCR was also
performed by direct comparison of fold-changes ob-
tained by the two methods only in the subset of samples
analyzed by microarrays (n = 3–4 per group). Expression
levels of 7 of the above genes and additional randomly
selected 5 genes (MCM5, ADK, APOH, MTL2A and
Figure 1 Hierarchical clustering analysis of genes differentially
regulated by PCB 153. Analysis was performed based on
log2-transformed ratio values of 160 genes differentially regulated,
between the 8 m/kg BW PCB 153 dose and control groups. Rows
represent genes and columns represent samples. Samples: Cont,
Control; 0.5 mg, 2 mg and 8 mg indicate, 0.5, 2 and 8 mg/kg BW
PCB 153, respectively. Color bar indicates log2-transformed ratio
values and corresponding colors (red, black and green for
up-regulated, not changing and down regulated, respectively).
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file 1: Table S1) were analyzed. For most of the genes,
fold-changes in expression levels with the two methods
showed good correlations (Additional file 2: Figures S1A-J).
Only two of the 12 genes (SRSF1 and APOH) showed poor
correlations with microarray data (Additional file 2: Figures
S1K and L). Confirming the microarray data, 10 out of the
12 genes were significantly up-regulated (p < 0.05, one-
tailed Student’s t-test) in the highest dose group (Additionalfile 2: Figures S1A-J). Thus, in general there is good con-
cordance between the two methods.
Functional enrichment analysis
Pathway and gene ontology analysis in DAVID
The 165 differentially regulated genes (Additional file 1:
Table S1) were used in pathway analysis using DAVID
[33] to see to most enriched pathways and biological
processes. Functional annotation in DAVID showed that
two of the top three significantly enriched clusters of
pathways and Gene Ontology (GO) biological processes
(BP) are related to lipid metabolism and DNA replica-
tion/ cell cycle (Table 1). The different significantly
enriched GO BP and pathways in each of these two
major enriched pathways have overlapping list of con-
stituent genes as illustrated by the Venn diagrams for
lipid metabolism (Figure 3A) and DNA metabolism re-
lated genes (Figure 3B). For example, all or the majority
of the genes in DNA Replication, DNA repair and cell
cycle pathways and processes are the subset of genes
in the DNA metabolism biological process (Table 1,
Figure 3B). As expected, Reactome DNA replication
genes are a subset of Cell cycle genes, and all the genes
in GO BP Cellular response to stress are a subset of the
genes in Cellular response to stimulus (Table 1). The BP
Cellular response to stimulus shares many of the genes
(10 of 18) with DNA metabolism and Cell cycle, sugges-
ting that the stress response activated here is related to
DNA replication/ cell cycle (Figure 3B). The last signifi-
cantly enriched term (FDR < 1.3) in the last cluster con-
tains 3 genes (KIT, BAX, and SCRIB) and is related to
programmed cell death (not shown). In summary, the
significantly enriched functional annotations suggest that
pathways related to lipid metabolism and cell cycle were
affected by PCB 153 in cod liver. The up-regulation of
many DNA replication and mitotic cell cycle genes
suggests proliferative effect of PCB 153. Similarly, up-
regulation of all the genes in the Lipid metabolic process
(such as ACACA and ACSA) (Table 1) suggests lipogenic
effect of PCB 153.
Functional ontology analysis using MetaCore
Analysis of the differentially regulated genes using the
functional ontologies in MetaCore (GeneGo pathway
map, process network and GO process) resulted in sig-
nificant enrichment of many pathways and networks
mainly related to lipid metabolism, cell cycle, tissue re-
modeling and wound repair, immune response, stress
response, apoptosis and various signaling pathways
(Table 2, Additional file 2: Tables S2-4). Larger number
of processes and pathways were significantly enriched
using MetaCore, perhaps because of differences in
annotations between the databases used. Significantly
Figure 2 Selected genes up-regulated in PCB 153 treated fish in qPCR assay. Each panel represents a graph of fold-changes in mRNA
levels for the indicated gene in lipid metabolism (A-H) and cell cycle (I and J) related pathways. qPCR was performed on a larger sample size
(n = 8–10 per group) for all genes except FABP7 (C) for which, n = 3 for 2 mg/kg BW dose and n = 4 for each of the other groups. Contr, 0.5 mg,
2 mg and 8 mg indicate control, 0.5, 2 and 8 mg/kg BW PCB 153 doses, respectively. *p < 0.05, **p < 0.01 (one-way ANOVA and Dunnett’s multiple
comparison post-test).Data are presented as mean ± standard deviation.
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top 20 process networks are shown in Additional file 2:
Table S2, S3 and S4, respectively. Pathways and GO
processes associated with lipid metabolism and DNA
metabolism are among the top significantly enriched
(Additional file 2: Tables S2 and S3), which is consistent
with the enrichment analysis using DAVID (Table 1).
The map of the top scoring pathway related to lipid
metabolism (Table 2), SCAP/SREBP Transcriptional
Control of Cholesterol and FA Biosynthesis, is shown in
Figure 4. All the genes indicated on this pathway inclu-
ding genes coding for the sterol regulatory element-
binding protein 1 (SREBP1) and key genes of enzymes
in fatty acid biosynthesis (e.g. ACLY, ACAC) were up-
regulated (Figure 2, Additional file 1: Tables S1), sugges-
ting increased synthesis of fatty acids. SREBP1 plays key
role is transcriptional activation of the lipogenic enzyme
genes in the liver [34].The organ-specific toxicity ontologies in MetaCore
combine normal and pathological processes with organ-
specific gene markers (GeneGo). Enrichment analysis of
liver-specific toxicity ontologies was performed to ex-
plore effects on liver specific functions. Again, the top
enriched liver-specific Toxic Pathology Biomarkers, Toxicity
Processes, Pathway Maps, GO Processes, GO Molecular
Functions, GO Localizations and Drug and Xenobiotic
metabolism Enzymes highlight mainly lipid metabolism and
cell proliferation related events (Additional file 2: Figures
S2A-G). For example, the two top enriched Toxic Pa-
thology Biomarkers, Liver-lipid accumulation, macrovesicu-
lar (FDR = 0.09) and Liver-degeneration (FDR = 0.13) are
pathologies that might be attributed to up-regulation of lipo-
genic genes (Additional file 2: Figure S2A). The most signifi-
cant interaction network generated in MetaCore using the 8
genes in Liver-lipid accumulation, macrovesicular is shown
in (Additional file 2: Figure S2H). This network shows
Table 1 Annotation clusters with significantly enriched GO biological processes and pathways in PCB 153 treated
samplesa
Category Term FDR Gene/protein symbols
Annotation Cluster 1 Enrichment Score: 3.7
PANTHER_BP Lipid, fatty acid and steroid metabolism 0 ACSA, AUHM, PQLC3, SCD5, HMDH, GNPAT, PCY2, UD11,
STAR3, NSDHL, ACACA, SRBP1, FABP7N, ANXA4, PCTL,
GDPD2, ACLY, PPARG, FABPL, DHB12
GOTERM_BP Lipid metabolic process 0.2 ACSA, SCD5, APOH, HMDH, GNPAT, PCY2, KIT, UD11,
GPAT3, STAR3, NSDHL, ACACA, SRBP1, BAX, PLB1,
GDPD2, ACLY, MK14, PPARG, DHB12
GOTERM_BP Lipid biosynthetic process 4.2 ACSA, GPAT3, STAR3, ACACA, NSDHL, SCD5, ACLY, HMDH, PCY2, DHB12
Annotation Cluster 2 Enrichment Score: 2.2
GOTERM_BP DNA metabolic process 0 DNMT1, BAF, BLM, TYDP1, FEN1, NUP98, RTEL1,
MCM3, PPIA, MCM5, RMI1, DPOA2, BAX,
DPOD1, KC1E, FOS, PCNA, RECQ4
PANTHER_BP DNA metabolism 0.1 MCM5, DPOA2, DNMT1, DPOD1, BLM, TYDP1, KC1E,
FEN1, PCNA, RECQ4, RTEL1, MCM3
KEGG_PW DNA replication 0.2 MCM5, DPOA, DPOD1, FEN1, PCNA, MCM3
REACT_PW DNA Replication 0.2 MCM5, PSMD3, DPOA2, DPOD1, FEN1, PCNA, PSB7, MCM3
GOTERM_BP DNA replication 0.5 MCM5, RMI1, DPOA2, DPOD1, BLM, FEN1, NUP98, PCNA. MCM3
PANTHER_BP DNA repair 0.5 DPOD1, BLM, TYDP1, KC1E, FEN1, PCNA, RECQ4, RTEL1
GOTERM_BP Cellular response to stress 0.9 SYAC, BLM, E2AK2, TYDP1, FEN1, RTEL1, ETV5, SRBP1, BAX,
DPOD1, KC1E, MK14, FOS, PCNA, RECQ4
PANTHER_BP DNA replication 1.1 MCM5, DPOA2, DPOD1, BLM, FEN1, PCNA, MCM3
GOTERM_BP Cellular response to stimulus 1.8 SYAC, BLM, E2AK2, TYDP1, FEN1, RTEL1, ETV5, UD11, SRBP1,
BAX, DPOD1, KC1E, ERBB3, MK14, PPARG, FOS, PCNA, RECQ4
GOTERM_BP DNA-dependent DNA replication 3.0 MCM5, DPOD1, BLM, FEN1, MCM3
REACT_PW Cell Cycle, Mitotic 4.5 MCM5, PSMD3, DPOA2, DPOD1, KC1E, KNTC1, FEN1, NUP98, PCNA, PSB7, MCM3
Annotation Cluster 3 Enrichment Score: 2.0
GOTERM_BP Macromolecule localization 2.4 APOH, GNPTA, SNX12, KPCB, NUP98, SNX25, DVL1L,
VPS53, STAR3, EZRI, SNX18, DPOA2, BAX, YIF1A, GOT1B,
DUS16, APOM, PPARG, RFIP2, PCNA, FABL
aEnrichment analysis was performed for functional categories GO BP (PANTHER_BP_ALL and GOTERM_BP_ALL) and pathway (KEGG and Reactome) using DAVID
tools (functional annotation cluster). Only significant annotation terms (FDR < 5%) are shown. All the genes were up-regulated except four (KIT, UD11, PLB1, BAF,
E2AK2), which were down regulated.
Figure 3 Venn diagrams showing overlapping genes in enriched lipid metabolism (A) and DNA metabolism/ cell cycle (B) pathways
and processes in Table 1. Abbreviations for terms in Table 1: P_Lipid_met, PANTHER_BP Lipid, fatty acid and steroid metabolism; GO_Lipid_met,
GOTERM_BP Lipid metabolic process; Lipid_biosy, GOTERM_BP Lipid biosynthetic process. GO_DNA_met, GOTERM_BP DNA metabolic process;
GO_DNA_repl, GOTERM_BP DNA replication; Resp_Stim, GOTERM_BP Cellular response to stimulus; R_Cell_cy, Reactome_Pathway, Cell
Cycle, Mitotic.
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Table 2 Significantly enriched top 20 GeneGo pathwaysa
Maps p-value FDR Gene/protein symbols
SCAP/SREBP Transcriptional Control of
Cholesterol and FA Biosynthesis
6.0E-09 0 HMDH, SREBP1 (Golgi membrane), ACLY, ACSA,
SCD5, SREBP1 precursor, SREBP1 (nuclear), ACACA
Regulation of lipid metabolism_Regulation
of lipid metabolism via LXR, NF-Y and SREBP
2.1E-05 0 SREBP1 (Golgi membrane), ACLY,
SREBP1 precursor, SREBP1 (nuclear), ACACA
Adiponectin in pathogenesis of type 2 diabetes 1.2E-04 0 SREBP1 precursor, p38alpha (MAPK14),
SREBP1 (nuclear), ACACA
Immune response_Oncostatin M signaling via MAPK in mouse cells 2.6E-04 0 EGR1, PPAR-gamma, p38 MAPK, c-Fos
Development_Role of IL-8 in angiogenesis 2.8E-04 0 HMDH, SREBP1 (Golgi membrane),
SREBP1 precursor, SREBP1 (nuclear), c-Fos
Immune response_Oncostatin M signaling via MAPK in human cells 3.2E-04 0 EGR1, PPAR-gamma, p38 MAPK, c-Fos
Development_Gastrin in differentiation of the gastric mucosa 3.5E-04 0 PKC-beta, EGR1, PKC, cPKC (conventional)
Development_EGFR signaling pathway 4.2E-04 0 PKC-beta, p38 MAPK, p38alpha (MAPK14), c-Fos, Bax
Regulation of lipid metabolism_Regulation
of fatty acid synthase activity in hepatocytes
6.1E-04 0 SREBP1 (Golgi membrane), SREBP1 precursor, SREBP1 (nuclear)
Regulation of lipid metabolism_Insulin
regulation of fatty acid methabolism
1.2E-03 0 SREBP1 (Golgi membrane), ACLY,
SREBP1 precursor, SREBP1 (nuclear), ACACA
SREBP1 cross-talk with PXR, CAR and LXR 1.6E-03 0 SREBP1 (Golgi membrane), SREBP1 precursor, SREBP1 (nuclear)
G-protein signaling_Ras family GTPases in kinase cascades (schema) 1.6E-03 0 p38 MAPK, p38alpha (MAPK14), c-Fos
DNA damage_ATM / ATR regulation of G2 / M checkpoint 1.6E-03 0 BLM, p38alpha (MAPK14), GADD45 beta
Cell cycle_Transition and termination of DNA replication 2.0E-03 0.1 PCNA, FEN1, POLD cat (p125)
Apoptosis and survival_p53-dependent apoptosis 2.2E-03 0.1 p38alpha (MAPK14), GADD45 beta, Bax
Renin-Angiotensin-Aldosterone System 2.3E-03 0.1 PKC-beta, CaMK I, p38alpha (MAPK14), c-Fos
Neuroprotective action of lithium 2.4E-03 0.1 p38 MAPK, p38alpha (MAPK14), Dsh, Bax
SREBP1 cross-talk with PXR, CAR and LXR/ Rodent version 2.6E-03 0.1 SREBP1 (Golgi), SREBP1 precursor, SREBP1 (nuclear)
Development_Inhibition of angiogenesis by PEDF 2.6E-03 0.1 PPAR-gamma, p38 MAPK, Bax
DNA damage_ATM/ATR regulation of G1/S checkpoint 2.9E-03 0.1 PCNA, BLM, GADD45 beta
aOnly the significantly enriched top 20 pathways are shown here, with the full list presented in Additional file 2: Table S2.
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pathology related to lipid accumulation. Similarly, the top
liver-specific Toxicity Processes, Steatosis, development
(FDR = 0.15) and Cell cycle, processes involved in S-phase
(FDR = 0.68) (Additional file 2: Figure S2B) are related to
lipid accumulation and cell proliferation, respectively. The
list of liver-specific enriched Maps and GO processes
(Additional file 2: Figures S2C and D) are similar to the list
in Additional file 2: Table S2 and S3, respectively. GO
molecular functions and localizations also reflect the
top enriched lipid metabolism and cell cycle pathways
(Additional file 2: Figures S2E and F). The analysis also
showed enrichment of pathways mediated by AhR and the
nuclear receptors (CAR, FXR and LXR and PXR) associ-
ated with Drug and Xenobiotic metabolism Enzymes
(Additional file 2: Figure S2G). In mammals, the nuclear
receptors LXR, CAR and PXR are involved in regulation
of lipid metabolism, mainly through cross-talk with SRBP1
pathway (See Table 2) [35]. Enrichment of PXR/ CAR
mediated pathway is expected as PCB 153 is known to ac-
tivate these receptors [5]. Surprisingly, AhR mediated
regulation of Drug and Xenobiotic metabolism Enzymes isthe top enriched pathway with 17 genes involved (Additional
file 2: Figure S2G), although PCB 153 does not activate
AhR. The 17 genes in this pathway are CCL4, CNTNAP1,
FOS, HMGCR, ITPKB, MAPK14, MYO1D, PCNA,
POLA2, PSMA5, SREBF1 and TEAD3. The AhR signaling
pathway may however interact with these genes indirectly
and the enrichment here may reflect its diverse biological
functions and possible alternative mechanisms involved.
Interactome and network analysis using MetaCore
The MetaCore Interactome analysis tool was used to ex-
plore statistically significant interactions of the differen-
tially regulated genes (Additional file 1: Table S1). The
analysis option “Transcription Factors” was used to per-
form enrichment analysis of interactions based on tran-
scriptional regulation mechanisms, which generated a list
of significantly enriched (FDR < 0.05) transcription factors
(Additional file 2: Table S5). Here, enrichment shows that
a significantly higher proportion of genes in the up-loaded
list (compared to the total number of genes in the whole
database for the organism) show interactions with the
transcription factor. Many transcription factors involved
Figure 4 Map of SCAP/SREBP Transcriptional Control of Cholesterol and FA Biosynthesis. This is the top enriched GeneGo pathway
showing the differentially regulated genes (all up-regulated) indicated by thermometer-like symbols in red. For detailed legend see Figure 2 SH
in Additional file 2.
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E2F4, E2F6, EGR1and EGR2) and lipid metabolism
(N220, SREBP1 and SREBP2) were significantly enriched
(Additional file 2: Table S5), consistent with the top enrich-
ment of these two pathways. Interestingly, the top enriched
transcription factor N220 (ZNF638) is a regulator of adipo-
cyte differentiation and the lipogenic transcription factorsPPARG and SREBP1[36]. Among the transcription factors
enriched, early growth response 1 (EGR1) and Sterol regula-
tory element-binding protein 1 (SREBP1) were also up-
regulated in this study (Additional file 1: Table S1, Figure 2).
To build a network of interaction among the differen-
tially regulated genes in our experiment, the network
building tool in MetaCore with the “Direct interaction”
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nificant (FDR < 0.05) network (Figure 5). Remarkably,
this network reveals regulatory relationships between the
transcription factors and their target genes in the differ-
entially regulated list, highlighting activation of the two
main pathways lipid metabolism and cell cycle. Particu-
larly well illustrated is the interactions of EGR1, PPARG
and SRBP1 transcription factors that result in activation
of the lipogenic genes HMDH, fatty acid binding protein,
ACACA, ACLY, SCD5 and ACSA, which is supported
by the top enriched canonical pathway (Figure 4). The
network suggests activation of the transcription factors
through the MAPK (Mitogen-activated protein kinase)
pathway and potential cross-talk between the cell prolif-
eration and lipogenic pathways. The gene coding for
the transcription factor EGR1 is one of the most up-
regulated in this experiment (Additional file 1: Table S1,
Figure 2), which may suggest its importance in the regu-
lation of the differentially regulated genes. As indicated
EGR1 appears to occupy a central role in the network as it
is possibly activated via the p38 MAPK signaling pathway,
and interacts downstream with both proliferation and
lipogenic transcription factors (Figure 5). EGR1, known to
regulate many genes related to cell proliferation, apoptosis
and immune response [37,38], has also been implicated inFigure 5 A statistically significant network of interactions within the d
MetaCore was used for generation of the interaction networks. Only genesregulation of cholesterol biosynthesis genes [39], support-
ing the interactions depicted in the network shown here.
Gene Set Enrichment Analysis (GSEA)
GSEA uses the whole set of genes without pre-selection
to determine if a pre-defined set of genes constituting a
functional category show significant, concordant differ-
ences in expression between two biological states [32].
GSEA was performed here as an independent and com-
plementary method to the pathway analyses using DA-
VID and MetaCore, which were performed only on the
differentially regulated genes. GSEA is suited for modest
changes in gene expression since it draws its statistical
power from concordant differential expression of many
genes within a gene set and their correlation to one of
the two biological states under comparison [40]. In this
analysis, all cod genes on the array that could be mapped
to putative human orthologs were ranked based on rela-
tive expression correlation from highest absolute levels
in the PCB 153 groups to the lowest levels. The predom-
inant gene sets significantly enriched are the Reactome
gene sets related to DNA metabolism and cell cycle
(Table 3, Additional file 3: Table S6). Table 3 shows the
significantly enriched gene sets of the Reactome (only
the top 20), GenMAPP (Gene Map Annotator andifferentially regulated genes. The “Direct interaction” algorithm in
with direct connections in the network are shown.
Table 3 Gene sets enriched in PCB 153 treated samplesa
Reactome gene set SIZE NES NOM p-val FDR q-val
SYNTHESIS_OF_DNA 61 2.0 3.1E-03 0.09
DNA_STRAND_ELONGATION 25 1.9 1.4E-02 0.05
M_G1_TRANSITION 52 1.9 7.2E-03 0.04
S_PHASE 74 1.9 7.1E-03 0.05
ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX 40 1.9 0 0.04
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX 26 1.9 3.0E-02 0.04
ORC1_REMOVAL_FROM_CHROMATIN 41 1.8 0 0.05
ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS 34 1.8 6.1E-03 0.06
SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1 25 1.8 7.2E-03 0.05
G1_S_TRANSITION 76 1.8 1.3E-02 0.05
ER_PHAGOSOME_PATHWAY 30 1.7 4.1E-03 0.06
CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX 32 1.7 3.0E-03 0.05
TRNA_AMINOACYLATION 26 1.7 2.7E-02 0.05
SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21 31 1.7 1.1E-02 0.05
MITOTIC_G1_G1_S_PHASES 90 1.7 1.6E-02 0.05
VIF_MEDIATED_DEGRADATION_OF_APOBEC3G 25 1.7 1.0E-02 0.05
TRIGLYCERIDE_BIOSYNTHESIS 30 1.7 9.1E-03 0.05
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS 28 1.7 4.3E-02 0.06
GLOBAL_GENOMIC_NER_GG_NER 25 1.7 1.7E-02 0.06
GenMAPP gene set SIZE NES NOM p-val FDR q-val
DNA_REPLICATION_REACTOME 29 2.0 0.021 0.03
AMINOACYL_TRNA_BIOSYNTHESIS 15 1.9 0.020 0.03
G1_TO_S_CELL_CYCLE_REACTOME 41 1.6 0.058 0.20
GLYCEROPHOSPHOLIPID_METABOLISM 32 1.6 0.020 0.21
KEGG gene set SIZE NES NOM p-val FDR q-val
DNA_REPLICATION 30 1.9 0.027 0.04
NUCLEOTIDE_EXCISION_REPAIR 31 1.6 0.025 0.24
OXIDATIVE_PHOSPHORYLATION 50 1.6 0.047 0.18
aOnly significantly enriched (FDR q-value < 0.25) top 20 Reactome gene sets and all significant GenMAPP and KEGG gene sets are shown. Gene sets are ranked by
normalized enrichment score (NES). SIZE and NOM p-val, indicate number of core genes in the enriched gene set and Nominal p-value, respectively.
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Genes and Genomes) databases. Gene sets related to
lipid metabolism, triglyceride biosynthesis and glycero-
phospholipid metabolism were among the significantly
enriched (Additional file 3: Table S6). Many more Reac-
tome gene sets (total 56) were significantly enriched
(FDR < 0.25), compared to only 4 and 3 for GenMAPP
and KEGG, respectively (Table 3, Additional file 3: Table
S6). Most of the Reactome gene sets are associated with
DNA repair, replication and cell cycle (Additional file 3:
Table S6). Other top enriched Reactome gene sets are
mainly related to immune response, apoptosis, respira-
tory electron transport, translation and circadian clock.
The top significantly enriched gene sets (Table 3, Add-
itional file 3: Table S6) are largely similar to the enriched
pathways using DAVID and MetaCore (Tables 1 and 2,Additional file 2: Tables S2, S3 and S4, Additional file 3:
Tables S6), which mainly highlighted pathways associ-
ated with DNA metabolism, cell cycle, lipid metabolism,
apoptosis, immune response and, stress response. In
Figure 6, enrichment plots for top enriched Reactome
pathways, synthesis of DNA (A) with the corresponding
leading edge genes (B), and triglyceride biosynthesis (C),
with the corresponding leading edge genes (D) are
shown. Genes in the enriched gene sets have higher
enrichment scores (ES) and tend to have hits clustered
towards the top of the sorted gene list (Figures 6A and
C), suggesting their modulation by PCB 153. The leading
edge list in the top gene set synthesis of DNA (Figure 6B)
contains most of the genes in the Reactome pathways
DNA replication and Cell cycle enriched in pathway analysis
using DAVID (Table 1). Similarly, the leading edge list in the
Figure 6 Enrichment plots for representative gene sets in Table 3. Enrichment plots for the top genes set Reactome pathway synthesis of
DNA (A) and the corresponding heat map for the “leading edge genes” (B). The upper panel (A) shows a plot of enrichment scores (ES) versus
rank positions of gene set members. Similar enrichment plot for the Reactome pathway triglyceride metabolism (C) and the corresponding heat
map for the “leading edge genes” (D) are shown. On the horizontal axes (A and C), the genes are sorted based on expression correlation (absolute
Pearson ranking metric) with PCB 153 treated samples (genes with high correlation, top ranked on the left end). The “hit” positions (vertical lines) of
genes are shown on the horizontal bars colored from deep red (top rank) to light blue (lowest rank). Genes with the hits clustered before each peak
constitute “leading edge” list up- or down-regulated in PCB 153 treated samples, and are shown on the heat map on the right of each plot (B and D).
The heat maps show relative expression levels from deep red (highest) to dark blue (lowest) of the leading edge genes in each fish of the control, 0.5,
2 and 8 mg/kg BW PCB 153 treated groups (n = 3–4 per group) as indicated. NES, normalized ES; FDR q, False Discovery Rate q-value.
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http://www.biomedcentral.com/1471-2164/15/481gene set triglyceride biosynthesis (Figure 6D) consists of
genes coding for enzymes in de novo synthesis of glyceroli-
pids such as ACLY, ACACA, FASN, GPAT, AGPAT3,
AGPAT5, and AGPAT9, some of which are also present in
the enriched lipid synthesis biological processes in DAVID
(Table 1). The up-regulation of these genes may indicateincreased lipid synthesis in PCB 153 treated fish liver, in
agreement with the results from analysis using DAVID
and MetaCore.
In summary, pathways, processes and networks related
to DNA replication, cell cycle and lipid metabolism were
consistently enriched using the different methods of
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DNA replication and cell cycle related genes suggests
that PCB 153 increases cell proliferation in the liver of
cod. In agreement with our results, PCB 153 has been
shown to increase hepatocyte proliferation and act as
liver tumor promoter in rats [10]. Some of the up-
regulated genes coding for enzymes such as ACLY,
ACACA and FASN (Figure 4, Figure 6D) are important in
de novo lipid biosynthesis pathway [41], suggesting in-
creased lipogenesis in PCB 153 treated fish. For example,
ACACA catalyzes the rate-limiting reaction in the synthe-
sis of long-chain fatty acids [42].
Transcriptional activation of both cell cycle and lipo-
genic genes has been observed during adipogenesis in
mammalian model systems [43]. It is not clear if the
simultaneous up-regulation of cell cycle and lipogenic
genes in cod liver is mechanistically related to these adi-
pogenesis processes in mammalian systems. It is possible
that up-regulation of genes associated with cell cycle
progression is related to activation of immune response
pathways observed here or liver tumor promoting effects
of PCB 153, as shown in rats [10]. However, the tran-
scriptional activation of lipogenic genes in cod liver
treated by PCB 153 appears to be supported by recent
studies that have documented adipogenic effects of PCBs
and other environmental chemicals [11,12,15]. In mice,
it was reported that bisphenol A increased hepatic ex-
pression of lipogenic genes and lipid accumulation [44].
In pre-adipogenic fibroblast 3T3-L1 cell culture studies,
PCB 153 and other chemicals have also been shown to
increase transcription of lipogenic marker genes, lipid
accumulation and adipogenic differentiation [16,19,20].
A recent study showed that mice fed with a combination
of PCB 153 and high-fat-diet showed increased visceral
adiposity, hepatic steatosis, plasma adipokines, and up-
regulation of hepatic lipid biosynthesis and down- regu-
lation of β-oxidation genes [18]. In our experiment,
significant changes were not observed in expression of
β-oxidation genes, although mRNA levels of the key
gene of this pathway, liver carnitine palmitoyltransferase
1A (CPT1A) showed a non-significant (FDR > 10%) de-
crease (expression ratio 0.61 in the highest dose group).
Phospholipase B1 (PLB1) among the down-regulated
genes (Additional file 1: Table S1) may also be related to
lipid degradation. Our hypothesis that transcriptional ac-
tivation of lipid biosynthesis genes could be attributed to
lipogenic effect of PCB 153 is supported by these stud-
ies. Although species differences should be considered in
the comparison with mammalian systems, our results
appear to be consistent with conservation of lipid me-
tabolism and adipogenesis processes in fish and mam-
mals [45,46]. Indeed, zebrafish (D. rerio) is increasingly
used as a model organism in research on obesity and
related metabolic diseases [21-23]. Thus, our resultsshowing increased transcription of lipogenic genes in the
liver of cod treated with PCB 153 can provide relevant
insights into potential effects in mammals.
Apart from cell cycle and lipid metabolism pathways,
other significantly enriched pathways are mainly asso-
ciated with immune response, apoptosis, stress response
and tissue remodeling, and they are probably related to
general toxicity by PCB 153. Some of the genes in these
pathways (e.g. stress response and apoptosis) have also sig-
nificant overlap with the genes in lipid metabolism and cell
cycle pathways (Tables 1 and 2, Additional file 2: Table S2).
Apoptosis and immune response pathways have been
previously reported to be affected in transcriptomics and
proteomics studies in response to environmental contami-
nants in cod and other fish [26,28,47-50]. Studies in higher
organisms have also shown that PCB 153 can modulate
the immune system [8,51].
Conclusions
Gene expression analysis in the liver of cod treated with
PCB 153 indicated transcriptional activation of genes
mainly associated with cell cycle, DNA replication, lipid
metabolism, immune response, apoptosis and stress
response pathways. The constituent genes in the two
major affected pathways, cell cycle and lipid biosynthesis
were mostly up-regulated, suggesting increased cell
proliferation and lipid synthesis in PCB 153 treated cod
liver. The results provide new insights into mechanisms
of toxicity of PCB 153.
Methods
Fish exposure and sampling
Fish exposure and sampling has been described previ-
ously [9]. Briefly, juvenile Atlantic cod of mixed genders
(G. morhua) approximately 1.5 years old with 220–530 g
of body weight (BW) were kept in 500 L tanks and sup-
plied with continuously flowing seawater at temperature
of 10°C. A 12:12 h light/dark cycle was used and the fish
were fed daily for 8 h with commercial pellets (EWOS,
Bergen, Norway). After acclimation for 6 days, the fish
were injected (i.p.) with 0, 0.5, 2 or 8 mg/kg body weight
PCB 153 (2,2′,4,4′,5,5′- hexachlorobiphenyl) (98.3% pu-
rity, Chem Service, West Chester, USA). The doses were
given in two injections, half of the dose on the first day
and the second half after one week. PCB 153 was dis-
solved in a vehicle of 20% acetone and 80% soybean oil.
The control fish were injected with the vehicle only. The
fish were sacrificed 14 days after the first injection and
liver samples were frozen in liquid nitrogen and stored
at −80°C until use. At the end of the experiment, che-
mical analysis showed liver burden of PCB 153 increased
to approximately 4 times the maximum total body bur-
den from the injected doses [9], reflecting the tendency
of highly lipophilic compounds like PCBs to accumulate
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ment was approved by the National Animal Research
Authority.
RNA extraction
Total RNA isolation from liver samples, determination
of concentration and quality assessment was performed
as described before [28]. RNA samples from vehicle con-
trol, 0.5 and 2 and 8 mg/kg BW PCB 153 doses (n = 3
for 2 mg/kg BW dose, and n = 4 for each of the other
groups) were submitted to Roche NimbleGen for labe-
ling and hybridization.
Microarray design and hybridization
Microarray design and hybridization has been described pre-
viously [28]. Briefly, Atlantic cod 135 K oligonucleotide ar-
rays were designed from a 44 k cDNA collection [27] and
manufactured by Roche Nimblegen (Madison, WI). The
array contains 125,825 probes derived from the G. morhua
sequences (3 or more probes per cDNA sequence) and
11,779 Nimblegen control probes. RNA samples from con-
trol fish (n = 4), 0.5 mg/kg BW PCB 153 (n = 4), 2 mg/kg
BW PCB 153 (n = 3) and 8 mg/kg BW PCB 153 (n = 4)
doses were submitted to Roche NimbleGen for hybridization.
For each sample, double strand cDNA labelled with Cy3 was
hybridized on the array according to protocols in Gene
Expression User Guide (Roche NimbleGen, Madison, WI).
Microarray data analysis
Filtering and analysis of differential regulation was per-
formed essentially as described before [28], with the fol-
lowing modifications. Expression ratios were (calculated
by dividing fluorescent intensity values in each sample by
average intensity value of control sample), log2-trans-
formed and differentially regulated genes were identified
using Significance Analysis of Microarrays (SAM) [52] im-
plemented in J-Express [53] (Molmine, Bergen, Norway).
For identification of differentially regulated genes, the
control and 8 mg/kg BW PCB 153 dose groups were com-
pared using SAM, and genes were considered differentially
regulated at a maximum False Discovery Rate (FDR) of
10%. With this threshold, a total of 160 (139 up-regulated
and 21 down-regulated) genes were found to be differen-
tially regulated. No differentially expressed genes were de-
tected at FDR < 5%. Therefore, a less stringent 10% FDR
cut-off was chosen for differential expression. No genes
met the criteria for differential regulation using SAM with
the same cut-off (FDR maximum of 10%) for the 0.5 and
2 mg/kg BW PCB 153 doses. Unsupervised hierarchical
clustering analysis of the 160 differentially regulated genes
was performed using Cluster3 software with average link-
age distance metric [54]. Venn diagrams were drawn using
an online tool Venny http://bioinfogp.cnb.csic.es/tools/
venny/). The array data have been deposited in NCBI’sGene Expression Omnibus (GEO) database (GEO acces-
sion GSE43733).
Annotation and pathway analysis
For pathway analysis using the well annotated mamma-
lian genome and proteome databases and tools, the
Atlantic cod genes were mapped to human orthologs as
described before [28]. Pathway enrichment analysis was per-
formed in DAVID (Database for Annotation, Visualization
and Integrated Discovery) [33] using Gene Ontology (GO),
KEGG and Reactome databases. Enrichment analysis for
GeneGo functional ontologies (Pathway Maps, Process
Networks and GO processes), and analysis using Inter-
actome and Network building tools was performed in Meta-
Core™ (GeneGo, St. Joseph, MI) [55]. The MetaCore default
setting of false discovery rate (FDR) < 0.05 was used as
threshold for significance in enrichment analysis.
Gene Set Enrichment Analysis (GSEA)
Expression data for Atlantic cod genes that could be
mapped to putative human orthologs (BLASTX with
human UniProtKB/Swiss-Prot database, E-value < 10−6)
(8.2 k genes in total) were used for gene set enrichment
analysis (GSEA) [32]. Gene symbols for the 8.2 k unique
genes were used as identifiers to perform GSEA. GSEA
software and gene sets in the Molecular Signatures
Database (MSigDB) [56] at Broad Institute (http://www.
broadinstitute.org/gsea/index.jsp) were used. GSEA was
performed with the control, 0.5, 2 and 8 mg/kg BW PCB
153 doses as continuous class labels with 1000 permuta-
tions of phenotypes. The absolute Pearson correlation
metric was selected for ranking genes in descending order.
The option for absolute correlation was chosen for rank-
ing since it places the most differentially regulated (both
up-regulated and down regulated) genes at the top of the
ranked order and the least changing genes at the bottom.
The curated Reactome, GenMAPP and KEGG gene sets
in MSigDB were used. Gene sets enriched with FDR <
0.25 were considered significant as recommended [32].
Quantitative real-time PCR (qPCR)
For each sample, cDNA synthesis was performed from
total RNA (1.0 μg) using reverse- SuperScript III First-
Strand Synthesis System for RT-PCR in 20 μL reaction
as described in the manufacturer’s protocols (Invitro-
gen). qPCR assay and analysis was performed as de-
scribed before [28]. Results are presented as means ±
standard deviations. For confirmation of microarray re-
sults by qPCR, statistical analysis was performed on
log2-transformed fold changes of expression (treated/
control) using one-tailed Student’s t-test, and p < 0.05
was considered significant. For the qPCR assay of larger
sample size, two samples (one from control and one
from 2 mg/kg BW PCB 153 treated group) were found
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GraphPad outlier calculator (http://graphpad.com/quick-
calcs/Grubbs1.cfm) and excluded from the analysis. For
the qPCR assay of larger sample size, statistical analysis
of log2-transformed fold-changes was performed using
one-way ANOVA and Dunnett’s multiple comparison
post-test (GraphPad Prism Software, La Jolla, CA, USA).Additional files
Additional file 1: Table S1. The file contains 165 genes differentially
regulated by PCB 153, which were used in pathway analysis.
Additional file 2: Figure S1. Comparison of fold changes of expression
by microarray and qPCR; Figure S2. Enriched liver-specific ontologies;
Table S2. A full list of significantly enriched GeneGo pathway maps;
Table S3. Significantly enriched GO Processes; Table S4. significantly
enriched top 20 GeneGo process networks; Table S5. significantly
enriched Transcription Factors.
Additional file 3: Is an excel document with a full list of
significantly enriched Reactome gene sets.Abbreviations
PCB: Polychlorinated biphenyl; POP: Persistent organic pollutant; BW: Body
weight; AhR: Aryl hydrocarbon receptor; SXR: Steroid and xenobiotic
receptor; PXR: Pregnane X receptor; CAR: Constitutive androstane receptor;
DAVID: Database for Annotation, Visualization and Integrated Discovery;
SAM: Significance Analysis of Microarrays; FDR: False Discovery Rate;
qPCR: Quantitative real-time polymerase chain reaction; GSEA: Gene Set
Enrichment Analysis; FABP: Fatty acid binding protein; SREBP: Sterol
regulatory element-binding protein; PPARG: Peroxisome proliferator-activated
receptor gamma; PCNA: Proliferating Cell Nuclear Antigen; SCAP: SREBP
chaperone; GO: Gene Ontology; BP: Biological process; ACLY: ATP citrate
lyase; ACACA: Acetyl-CoA carboxylase (ACC); ACSA: Acetyl-CoA synthetase;
FASN: Fatty acid synthase; SCD5: Stearoyl-CoA desaturase 5; E2F1: EGR1, Early
growth response 1; MAPK: Mitogen-activated protein kinase; KEGG: Kyoto
Encyclopedia of Genes and Genomes; GenMAPP: Gene Map Annotator and
Pathway Profiler; MCM5: Minichromosome Maintenance Complex Component
5; ES: Enrichment score; NES: Normalized ES; Nom p-val: Nominal p-value.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
FY coordinated array design and data acquisition, performed array data analysis
and drafted the manuscript. OAK coordinated the project, participated in data
analysis and reviewed the manuscript. ME participated in array data validation
experiments, and reviewed the manuscript. CH participated in microarray
experiment design, data analysis and reviewed the manuscript. AG conceived
of the study, participated in its design, coordinated the study, and reviewed the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
The authors thank the Genofisk Consortium and the Cod Genome
Sequencing Project Team for sharing data in advance of the public release
of the cod genome data. The project (iCOD) is funded by the Norwegian
Research Council (project 192441/I30).
Author details
1Department of Molecular Biology, University of Bergen, Bergen, Norway.
2Department of Biology, University of Bergen, Bergen, Norway. 3Diabetes and
Nutritional Sciences Division, King’s College London, London, UK.
Received: 1 April 2014 Accepted: 11 June 2014
Published: 17 June 2014References
1. Safe SH: Polychlorinated biphenyls (PCBs): Environmental impact,
biochemical and toxic responses, and implications for risk assessment.
Crit Rev Toxicol 1994, 24(2):87–149.
2. Jonsson A, Gustafsson O, Axelman J, Sundberg H: Global accounting of
PCBs in the continental shelf sediments. Environ Sci Technol 2003,
37(2):245–255.
3. Judd N, Griffith WC, Faustman EM: Contribution of PCB exposure from
fish consumption to total dioxin-like dietary exposure. Regul Toxicol
Pharmacol 2004, 40(2):125–135.
4. McFarland VA, Clarke JU: Environmental occurrence, abundance, and
potential toxicity of polychlorinated biphenyl congeners: considerations
for a congener-specific analysis. Environ Health Perspect 1989, 81:225–239.
5. Al-Salman F, Plant N: Non-coplanar polychlorinated biphenyls (PCBs)
are direct agonists for the human pregnane-X receptor and constitutive
androstane receptor, and activate target gene expression in a
tissue-specific manner. Toxicol Appl Pharmacol 2012, 263(1):7–13.
6. Hurst CH, Waxman DJ: Interactions of Endocrine-active environmental
chemicals with the nuclear receptor PXR. Toxicol Environ Chem 2005,
87(1–4):299–311. 287.
7. Hedge JM, DeVito MJ, Crofton KM: In vivo acute exposure to
polychlorinated biphenyls: effects on free and total thyroxine in rats.
Int J Toxicol 2009, 28(5):382–391.
8. Lyche JL, Oskam IC, Skåe JU, Reksen O, Sweeney T, Dahl E, Farstad W,
Ropstad E: Effects of gestational and lactational exposure to low doses
of PCBs 126 and 153 on anterior pituitary and gonadal hormones and
on puberty in female goats. Reprod Toxicol 2004, 19(1):87–95.
9. Berg K, Puntervoll P, Klungsøyr J, Goksøyr A: Brain proteome alterations
of Atlantic cod (Gadus morhua) exposed to PCB 153. Aquat Toxicol 2011,
105(3–4):206–217.
10. Dean CE, Benjamin SA, Chubb LS, Tessari JD, Keefe TJ: Nonadditive hepatic
tumor promoting effects by a mixture of two structurally different
polychlorinated biphenyls in female rat livers. Toxicol Sci 2002, 66(1):54–61.
11. Alonso-Magdalena P, Quesada I, Nadal A: Endocrine disruptors in the
etiology of type 2 diabetes mellitus. Nat Rev Endocrinol 2011, 7(6):346–353.
12. Casals-Casas C, Desvergne B: Endocrine disruptors: from endocrine to
metabolic disruption. Annual Rev Physiol 2011, 73:135–162.
13. Grün F, Blumberg B: Endocrine disrupters as obesogens. Mol Cell
Endocrinol 2009, 304(1–2):19–29.
14. Lee D-H, Lee I-K, Song K, Steffes M, Toscano W, Baker BA, Jacobs DR Jr: A
strong dose–response relation between serum concentrations of persist-
ent organic pollutants and diabetes - results from the National Health
and Examination Survey 1999–2002. Diabetes Care 2006, 29(7):1638–1644.
15. Ruzzin J, Lee D-H, Carpenter DO, Jacobs DR Jr: Reconsidering metabolic
diseases: the impacts of persistent organic pollutants. Atherosclerosis
2012, 224(1):1–3.
16. Ruzzin J, Petersen R, Meugnier E, Madsen L, Lock EJ, Lillefosse H, Ma T,
Pesenti S, Sonne SB, Marstrand TT, Malde MK, Du ZY, Chavey C, Fajas L,
Lundebye AK, Brand CL, Vidal H, Kristiansen K, Frøyland L: Persistent
organic pollutant exposure leads to insulin resistance syndrome.
Environ Health Perspect 2010, 118(4):465–471.
17. Thayer KA, Heindel JJ, Bucher JR, Gallo MA: Role of environmental
chemicals in diabetes and obesity: a national toxicology program
workshop review. Environ Health Perspect 2012, 120(6):779–789.
18. Wahlang B, Falkner KC, Gregory B, Ansert D, Young D, Conklin DJ, Bhatnagar
A, McClain CJ, Cave M: Polychlorinated biphenyl 153 is a diet-dependent
obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J
mice. J Nutr Biochem 2013, 24(9):1587–1595.
19. Hu P, Chen X, Whitener RJ, Boder ET, Jones JO, Porollo A, Chen J, Zhao L:
Effects of parabens on adipocyte differentiation. Toxicol Sci 2013,
131(1):56–70.
20. Taxvig C, Dreisig K, Boberg J, Nellemann C, Schelde AB, Pedersen D, Boergesen
M, Mandrup S, Vinggaard AM: Differential effects of environmental chemicals
and food contaminants on adipogenesis, biomarker release and PPAR
gamma activation. Mol Cell Endocrinol 2012, 361(1–2):106–115.
21. Oka T, Nishimura Y, Zang L, Hirano M, Shimada Y, Wang Z, Umemoto N,
Kuroyanagi J, Nishimura N, Tanaka T: Diet-induced obesity in zebrafish
shares common pathophysiological pathways with mammalian obesity.
BMC Physiol 2010, 10(1):21.
22. Seth A, Stemple DL, Barroso I: The emerging use of zebrafish to model
metabolic disease. Dis Model Mech 2013, 6(5):1080–1088.
Yadetie et al. BMC Genomics 2014, 15:481 Page 14 of 14
http://www.biomedcentral.com/1471-2164/15/48123. Tingaud-Sequeira A, Ouadah N, Babin PJ: Zebrafish obesogenic test: a tool for
screening molecules that target adiposity. J Lipid Res 2011, 52(9):1765–1772.
24. Eide M, Karlsen OA, Kryvi H, Olsvik PA, Goksøyr A: Precision-cut liver slices
of Atlantic cod (Gadus morhua): an in vitro system for studying the
effects of environmental contaminants. Aquat Toxicol 2013, http://dx.doi.
org/10.1016/j.aquatox.2013.10.027.
25. Karlsen OA, Bjørneklett S, Berg K, Brattås M, Bohne-Kjersem A, Grøsvik BE,
Goksøyr A: Integrative Environmental Genomics of Cod (Gadus morhua):
the Proteomics Approach. J Toxicol Environ Health-Part a-Curr Issues 2011,
74(7–9):494–507.
26. Kidd K, Holth TF, Thorsen A, Olsvik PA, Hylland K: Long-term exposure
of Atlantic cod (Gadus morhua) to components of produced water:
condition, gonad maturation, and gene expression. Can J Fish Aquat Sci
2010, 67(10):1685–1698.
27. Star B, Nederbragt AJ, Jentoft S, Grimholt U, Malmstrom M, Gregers TF, Rounge
TB, Paulsen J, Solbakken MH, Sharma A, Wetten OF, Lanzén A, Winer R, Knight
J, Vogel JH, Aken B, Andersen O, Lagesen K, Tooming-Klunderud A, Edvardsen
RB, Tina KG, Espelund M, Nepal C, Previti C, Karlsen BO, Moum T, Skage M, Berg
PR, Gjøen T, Kuhl H: The genome sequence of Atlantic cod reveals a unique
immune system. Nature 2011, 477(7363):207–210.
28. Yadetie F, Karlsen OA, Lanzen A, Berg K, Olsvik P, Hogstrand C, Goksøyr A:
Global transcriptome analysis of Atlantic cod (Gadus morhua) liver after
in vivo methylmercury exposure suggests effects on energy metabolism
pathways. Aquat Toxicol 2013, 126:314–325.
29. Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD,
Mount DR, Nichols JW, Russom CL, Schmieder PK, Serrrano JA, Tietge JE,
Villeneuve DL: Adverse outcome pathways: a conceptual framework to
support ecotoxicology research and risk assessment. Environ Toxicol Chem
2010, 29(3):730–741.
30. Martyniuk CJ, Griffitt RJ, Denslow ND: Omics in aquatic toxicology: not just
another microarray. Environ Toxicol Chem 2011, 30((1552–8618
(Electronic))):263–264.
31. Van Aggelen G, Ankley GT, Baldwin WS, Bearden DW, Benson WH, Chipman
JK, Collette TW, Craft JA, Denslow ND, Embry MR, Falciani F, George SG,
Helbing CC, Hoekstra PF, Iguchi T, Kagami Y, Katsiadaki I, Kille P, Liu L, Lord
PG, McIntyre T, O'Neill A, Osachoff H, Perkins EJ, Santos EM, Skirrow RC,
Snape JR, Tyler CR, Versteeg D, Viant MR, Volz DC, Williams TD, Yu L:
Integrating omic technologies into aquatic ecological risk assessment
and environmental monitoring: hurdles, achievements, and future
outlook. Environ Health Perspect 2010, 118(1):1–5.
32. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA,
Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set
enrichment analysis: a knowledge-based approach for interpreting
genome-wide expression profiles. Proc Natl Acad Sci U S A 2005, 102
(43):15545–15550.
33. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA:
DAVID: Database for annotation, visualization, and integrated discovery.
Genome Biol 2003, 4:3.
34. Shimano H: Sterol regulatory element-binding proteins (SREBPs): transcrip-
tional regulators of lipid synthetic genes. Prog Lipid Res 2001, 40(6):439–452.
35. Roth A, Looser R, Kaufmann M, Blättler SM, Rencurel F, Huang W, Moore DD,
Meyer UA: Regulatory cross-talk between drug metabolism and lipid
homeostasis: constitutive androstane receptor and pregnane X receptor
increase Insig-1 expression. Mol Pharmacol 2008, 73(4):1282–1289.
36. Meruvu S, Hugendubler L, Mueller E: Regulation of adipocyte
differentiation by the zinc finger protein ZNF638. J Biol Chem 2011,
286(30):26516–26523.
37. DeLigio JT, Zorio DA: Early growth response 1 (EGR1): a gene with as many
names as biological functions. Cancer Biol Ther 2009, 8(20):1889–1892.
38. Thiel G, Cibelli G: Regulation of life and death by the zinc finger
transcription factor Egr-1. J Cell Physiol 2002, 193(3):287–292.
39. Gokey NG, Lopez-Anido C, Gillian-Daniel A, Svaren J: Early growth response
1 (Egr1) regulates cholesterol biosynthetic gene expression. J Biol Chem
2011, 286(1083-351× (Electronic)):29501–29510.
40. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J,
Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ,
Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES,
Hirschhorn JN, Altshuler D, Groop LC: PGC-1 alpha-responsive genes
involved in oxidative phosphorylation are coordinately downregulated
in human diabetes. Nat Genet 2003, 34(3):267–273.41. Roberts R, Hodson L, Dennis AL, Neville MJ, Humphreys SM, Harnden KE,
Micklem KJ, Frayn KN: Markers of de novo lipogenesis in adipose tissue:
associations with small adipocytes and insulin sensitivity in humans.
Diabetologia 2009, 52(5):882–890.
42. Wakil SJ, Stoops JK, Joshi VC: Fatty acid synthesis and its regulation.
Annu Rev Biochem 1983, 52:537–579.
43. Tang QQ, Lane MD: Adipogenesis: From Stem Cell to Adipocyte. In
Annual Review of Biochemistry, Vol 81. vol. 81st edition. Edited by Kornberg
RD. Palo Alto: Annual Reviews; 2012:715–736.
44. Marmugi A, Ducheix S, Lasserre F, Polizzi A, Paris A, Priymenko N, Bertrand-
Michel J, Pineau T, Guillou H, Martin PGP, Mselli-Lakhal L: Low doses of
bisphenol a induce gene expression related to lipid synthesis and
trigger triglyceride accumulation in adult mouse liver. Hepatology 2012,
55(2):395–407.
45. Flynn EJ III, Trent CM, Rawls JF: Ontogeny and nutritional control of
adipogenesis in zebrafish (Danio rerio). J Lipid Res 2009, 50(8):1641–1652.
46. Schlegel A, Stainier DYR: Lessons from “lower” organisms: What worms,
flies, and zebrafish can teach us about human energy metabolism.
Plos Genetics 2007, 3(11):2037–2048.
47. Asker N, Kristiansson E, Albertsson E, Larsson D, Förlin L: Hepatic transcriptome
profiling indicates differential mRNA expression of apoptosis and immune
related genes in eelpout (Zoarces viviparuscaught at Göteborg harbor,
Sweden. Aquat Toxicol 2013, 130:58–67.
48. Bohne-Kjersem A, Skadsheim A, Goksøyr A, Grøsvik BE: Candidate
biomarker discovery in plasma of juvenile cod (Gadus morhua) exposed
to crude North Sea oil, alkyl phenols and polycyclic aromatic
hydrocarbons (PAHs). Mar Environ Res 2009, 68(5):268–277.
49. Leaver MJ, Diab A, Boukouvala E, Williams TD, Chipman JK, Moffat CF,
Robinson CD, George SG: Hepatic gene expression in flounder chronically
exposed to multiply polluted estuarine sediment: absence of classical
exposure ‘biomarker’signals and induction of inflammatory, innate
immune and apoptotic pathways. Aquat Toxicol 2010, 96(3):234–245.
50. Lie KK, Lanzen A, Breilid H, Olsvik PA: Gene expression profiling in Atlantic
cod (Gadus morhua L.) from two contaminated sites using a custom-
made cDNA microarray. Environ Toxicol Chem 2009, 28(8):1711–1721.
51. Sagerup K, Larsen HJS, Skaare JU, Johansen GM, Gabrielsen GW: The toxic
effects of multiple persistent organic pollutant exposures on the
post-hatch immunity maturation of glaucous gulls. J Toxic Environ Health
A 2009, 72(14):870–883.
52. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays
applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001,
98(9):5116–5121.
53. Dysvik B, Jonassen I: J-Express: exploring gene expression data using
Java. Bioinformatics 2001, 17(4):369–370.
54. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display
of genome-wide expression patterns. Proc Natl Acad Sci 1998, 95
(25):14863–14868.
55. Ekins S, Bugrim A, Brovold L, Kirillov E, Nikolsky Y, Rakhmatulin E, Sorokina S,
Ryabov A, Serebryiskaya T, Melnikov A, Metz J, Nikolskaya T: Algorithms
for network analysis in systems-ADME/Tox using the MetaCore and
MetaDrug platforms. Xenobiotica 2006, 36(10–11):877–901.
56. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P,
Mesirov JP: Molecular signatures database (MSigDB) 3.0. Bioinformatics
2011, 27(12):1739–1740.
doi:10.1186/1471-2164-15-481
Cite this article as: Yadetie et al.: Liver transcriptome analysis of Atlantic
cod (Gadus morhua) exposed to PCB 153 indicates effects on cell cycle
regulation and lipid metabolism. BMC Genomics 2014 15:481.
